ArticleProceedings of the National Academy of Sciences of the United States of America2026
Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinoma.
Erika Testa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.